| 000 | 01633 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516022228.0 | ||
| 264 | 0 | _c20110406 | |
| 008 | 201104s 0 0 eng d | ||
| 022 | _a0301-0430 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKrmar, R T | |
| 245 | 0 | 0 |
_aAcute renal failure in dense deposit disease: complete recovery after combination therapy with immunosuppressant and plasma exchange. _h[electronic resource] |
| 260 |
_bClinical nephrology _cFeb 2011 |
||
| 300 |
_a4-10 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAcute Kidney Injury _xgenetics |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aComplement Activation |
| 650 | 0 | 4 |
_aComplement Factor H _xgenetics |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aDNA Mutational Analysis |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlomerulonephritis, Membranoproliferative _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aMethylprednisolone _xadministration & dosage |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPlasma Exchange |
| 650 | 0 | 4 | _aPulse Therapy, Drug |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHoltbäck, U | |
| 700 | 1 | _aLinné, T | |
| 700 | 1 | _aBerg, U B | |
| 700 | 1 | _aCelsi, G | |
| 700 | 1 | _aSöderberg, M P | |
| 700 | 1 | _aWernerson, A | |
| 700 | 1 | _aSzakos, A | |
| 700 | 1 | _aLarsson, S | |
| 700 | 1 | _aSkattum, L | |
| 700 | 1 | _aBárány, P | |
| 773 | 0 |
_tClinical nephrology _gvol. 75 Suppl 1 _gp. 4-10 |
|
| 999 |
_c20549863 _d20549863 |
||